Literature DB >> 526407

Labetalol infusion in acute myocardial infarction with systemic hypertension.

P G Marx, D S Reid.   

Abstract

1 Fifteen patients with suspected acute myocardial infarction and systemic BP of greater than 160/110 mmHg were treated with an incremental infusion of labetalol. 2 Systemic BPs were safely and effectively lowered to less than 130 mm Hg systolic or 90 mmHg diastolic in all pateints. 3 Heart rate, mean pulmonary artery wedge pressure cardiac index and stroke work index were significantly reduced. 4 The dose of labetalol varied from 30 mg--440 mg and was significantly higher (mean 295 mg) in those patients with pre-existing systemic hypertension compared with others (mean 133 mg). 5 No side-effects occurred and all patients survived to leave hospital.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526407      PMCID: PMC1429731     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Prognostic significance of acute systolic hypertension after myocardial infarction.

Authors:  K M Fox; I W Tomlinson; R W Portal; C P Aber
Journal:  Br Med J       Date:  1975-07-19

2.  Serial plasma adrenaline and noradrenaline levels in myocardial infarction using a new double isotope technique.

Authors:  D C Siggers; C Salter; D C Fluck
Journal:  Br Heart J       Date:  1971-11

3.  Protection of jeopardized ischemic myocardium by reduction of ventricular afterload.

Authors:  W E Shell; B E Sobel
Journal:  N Engl J Med       Date:  1974-09-05       Impact factor: 91.245

4.  Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure.

Authors:  D T Kelly; C E Delgado; D R Taylor; B Pitt; R S Ross
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

5.  Evaluation of pulmonary arterial end-diastolic pressure as an estimate of left ventricular end-diastolic pressure in patients with normal and abnormal left ventricular performance.

Authors:  R J Bouchard; J H Gault; J Ross
Journal:  Circulation       Date:  1971-12       Impact factor: 29.690

6.  Thirteenth Bowditch lecture. The determinants of myocardial oxygen consumption.

Authors:  E Braunwald
Journal:  Physiologist       Date:  1969-05

7.  Reduction of enzyme levels by propranolol after acute myocardial infarction.

Authors:  T Peter; R M Norris; E D Clarke; M K Heng; B N Singh; B Williams; D R Howell; P K Ambler
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

8.  Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction.

Authors:  M Chiariello; H K Gold; R C Leinbach; M A Davis; P R Maroko
Journal:  Circulation       Date:  1976-11       Impact factor: 29.690

9.  Intravenous diazoxide in treatment of hypertension associated with recent myocardial infarction.

Authors:  K P O'Brien; R R Grigor; P M Taylor
Journal:  Br Med J       Date:  1975-10-11
  9 in total
  10 in total

Review 1.  Comparison of labetalol with other anti-hypertensive drugs.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

2.  Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

Authors:  B N Prichard; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

3.  Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.

Authors:  B Silke; G I Nelson; R C Ahuja; S Choudhury; S H Taylor
Journal:  Ir J Med Sci       Date:  1983-05       Impact factor: 1.568

4.  The electrophysiological effects of intravenous labetalol in man.

Authors:  A Harley; H A Coverdale
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 5.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Role of labetalol in acute myocardial infarction.

Authors:  A D Timmis; M B Fowler; N S Jaggarao; R Vincent; D A Chamberlain
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

Review 7.  Combined receptor intervention and myocardial infarction.

Authors:  D A Chamberlain; R Vincent
Journal:  Drugs       Date:  1984       Impact factor: 9.546

8.  [Effectiveness and hemodynamic mechanism of action of blood pressure lowering by intravenous labetalol in patients with a critical increase in blood pressure].

Authors:  H P Schuster; B Ehlers; K F Bodmann; F Köhler
Journal:  Klin Wochenschr       Date:  1989-07-17

Review 9.  Perioperative hypertension management.

Authors:  Joseph Varon; Paul E Marik
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Clinical review: the management of hypertensive crises.

Authors:  Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2003-07-16       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.